C+62/100

Is Agilent Technologies (A) a risky stock?

Sector: Health Care Price: $132.84 Composite: 62/100

As of July 21, 2026, Clavix grades Agilent Technologies (A) C+ for risk, a composite score of 62 out of 100 on an A+ to F scale, which puts A in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind A's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how A scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
75
News sentimentscored, sourced recent coverage
32
Macro exposuresensitivity to rates, dollar, oil
70
Sector resiliencestrength vs the broad market
56
Price stabilitydrawdown and volatility
48

What's moving A's risk right now

Company-specific signals Clavix flags behind A's current grade, drawn from recent news and filings as of July 21, 2026.

Regulatory · raising risk

The vandalism incidents could increase pressure on Flock Safety to invest in more durable or tamper-resistant hardware, potentially raise insurance/liability concerns, and fuel th…

Guidance · mixed signal

In-line guidance removes a near-term catalyst in either direction, leaving the rating dependent on longer-term execution.

What a C+ grade means

On the Clavix A+ to F scale, A's composite of 62 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell A or any security. Grades are risk indicators, not predictions of return. Data may be delayed.